PL2931922T3 - Personalizowane biomarkery nowotworu - Google Patents
Personalizowane biomarkery nowotworuInfo
- Publication number
- PL2931922T3 PL2931922T3 PL13863107T PL13863107T PL2931922T3 PL 2931922 T3 PL2931922 T3 PL 2931922T3 PL 13863107 T PL13863107 T PL 13863107T PL 13863107 T PL13863107 T PL 13863107T PL 2931922 T3 PL2931922 T3 PL 2931922T3
- Authority
- PL
- Poland
- Prior art keywords
- cancer
- personalized biomarkers
- biomarkers
- personalized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737626P | 2012-12-14 | 2012-12-14 | |
| PCT/US2013/075015 WO2014093825A1 (en) | 2012-12-14 | 2013-12-13 | Personalized biomarkers for cancer |
| EP13863107.2A EP2931922B1 (en) | 2012-12-14 | 2013-12-13 | Personalized biomarkers for cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2931922T3 true PL2931922T3 (pl) | 2019-04-30 |
Family
ID=50934991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13863107T PL2931922T3 (pl) | 2012-12-14 | 2013-12-13 | Personalizowane biomarkery nowotworu |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9909186B2 (pl) |
| EP (1) | EP2931922B1 (pl) |
| ES (1) | ES2703764T3 (pl) |
| PL (1) | PL2931922T3 (pl) |
| WO (1) | WO2014093825A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4293125A3 (en) | 2012-12-10 | 2024-02-28 | Resolution Bioscience, Inc. | Methods for targeted genomic analysis |
| WO2014113204A1 (en) | 2013-01-17 | 2014-07-24 | Personalis, Inc. | Methods and systems for genetic analysis |
| WO2015031689A1 (en) | 2013-08-30 | 2015-03-05 | Personalis, Inc. | Methods and systems for genomic analysis |
| WO2015051275A1 (en) | 2013-10-03 | 2015-04-09 | Personalis, Inc. | Methods for analyzing genotypes |
| JP7441584B6 (ja) * | 2014-08-22 | 2024-03-15 | レゾリューション バイオサイエンス， インコーポレイテッド | 無細胞ＤＮＡ（ｃｆＤＮＡ）の定量的遺伝子解析のための方法 |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| US10125399B2 (en) | 2014-10-30 | 2018-11-13 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
| WO2017066785A1 (en) * | 2015-10-16 | 2017-04-20 | The Regents Of The University Of California, A California Corporation | Repetitive element (re)-based genome analysis and dynamic genetics surveillance systems |
| ES2856598T3 (es) | 2015-11-11 | 2021-09-27 | Resolution Bioscience Inc | Construcción de alta eficiencia de bibliotecas de ADN |
| US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
| WO2018039463A1 (en) | 2016-08-25 | 2018-03-01 | Resolution Bioscience, Inc. | Methods for the detection of genomic copy changes in dna samples |
| US20190309352A1 (en) * | 2016-11-16 | 2019-10-10 | Progenity, Inc | Multimodal assay for detecting nucleic acid aberrations |
| US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
| CN113166757A (zh) * | 2019-02-15 | 2021-07-23 | 宝生物工程（美国)有限公司 | 核酸文库的制备和分析方法 |
| CN109825583B (zh) * | 2019-03-01 | 2021-08-17 | 清华大学 | 人重复元件dna甲基化作为肝癌早期诊断的标记物及其应用 |
| EP4055610A4 (en) | 2019-11-05 | 2023-11-29 | Personalis, Inc. | ESTIMATION OF TUMOR PURITY FROM SINGLE SAMPLES |
| WO2022046635A1 (en) * | 2020-08-24 | 2022-03-03 | Dana-Farber Cancer Institute, Inc. | Enhanced sequencing following random dna ligation and repeat element amplification |
| US12297508B2 (en) | 2021-10-05 | 2025-05-13 | Personalis, Inc. | Customized assays for personalized cancer monitoring |
| WO2025059176A1 (en) * | 2023-09-15 | 2025-03-20 | The Johns Hopkins University | Assessing and treating cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955589A (en) | 1991-12-24 | 1999-09-21 | Isis Pharmaceuticals Inc. | Gapped 2' modified oligonucleotides |
| YU187991A (sh) | 1990-12-11 | 1994-09-09 | Hoechst Aktiengesellschaft | 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba |
| US5652099A (en) | 1992-02-12 | 1997-07-29 | Conrad; Michael J. | Probes comprising fluorescent nucleosides and uses thereof |
| US5446137B1 (en) | 1993-12-09 | 1998-10-06 | Behringwerke Ag | Oligonucleotides containing 4'-substituted nucleotides |
| DE4415370A1 (de) | 1994-05-02 | 1995-11-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| DE4438918A1 (de) | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| US5773649A (en) * | 1996-06-10 | 1998-06-30 | Centre De Recherche De L'hopital Sainte-Justine | DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells |
| EP0960210A4 (en) * | 1996-10-04 | 2004-06-09 | Chronix Biomedical | Diagnostic detection of nucleic acids |
| ATE280177T1 (de) | 1997-03-20 | 2004-11-15 | Hoffmann La Roche | Modifizierte primer |
| USH2191H1 (en) | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| US20070231823A1 (en) * | 2006-03-23 | 2007-10-04 | Mckernan Kevin J | Directed enrichment of genomic DNA for high-throughput sequencing |
| WO2010117817A2 (en) * | 2009-03-30 | 2010-10-14 | Life Technologies Corporation | Methods for generating target specific probes for solution based capture |
| CN102409048B (zh) | 2010-09-21 | 2013-10-23 | 深圳华大基因科技服务有限公司 | 一种基于高通量测序的dna标签文库构建方法 |
| EP2686451A4 (en) | 2011-03-18 | 2014-12-24 | Baylor Res Inst | LINE-1 HYPOMETHYLATION AS A BIOMARKER FOR EARLY BREAKING COLORECTAL CANCER |
| GB201106254D0 (en) * | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| US20150275308A1 (en) * | 2012-10-19 | 2015-10-01 | Sequenta, Inc. | Monitoring diffuse large b-cell lymphoma from peripheral blood samples |
-
2013
- 2013-12-13 PL PL13863107T patent/PL2931922T3/pl unknown
- 2013-12-13 WO PCT/US2013/075015 patent/WO2014093825A1/en not_active Ceased
- 2013-12-13 US US14/652,098 patent/US9909186B2/en active Active
- 2013-12-13 EP EP13863107.2A patent/EP2931922B1/en active Active
- 2013-12-13 ES ES13863107T patent/ES2703764T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9909186B2 (en) | 2018-03-06 |
| ES2703764T3 (es) | 2019-03-12 |
| EP2931922B1 (en) | 2018-10-17 |
| WO2014093825A1 (en) | 2014-06-19 |
| EP2931922A1 (en) | 2015-10-21 |
| EP2931922A4 (en) | 2016-07-27 |
| US20160053328A1 (en) | 2016-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2931922T3 (pl) | Personalizowane biomarkery nowotworu | |
| EP2825674A4 (en) | BIOMARKER FOR THYROID CANCER | |
| GB201213567D0 (en) | Biomarkers | |
| ZA201503280B (en) | Physical channel design for network-assisted d2d | |
| PL2714926T3 (pl) | Biomarkery raka płuca | |
| IL237436A0 (en) | A method for screening cancer | |
| GB201211982D0 (en) | Biomarker | |
| IL233803A0 (en) | Monocyte biomarkers for cancer detection | |
| PL2876447T3 (pl) | Sposób wykrywania nowotworu | |
| EP2831270B8 (en) | Biomarker for bladder cancer | |
| EP2994545A4 (en) | Dna methylation biomarkers for bladder cancer | |
| EP2985605A4 (en) | Method for detecting colon cancer | |
| EP2986326A4 (en) | Methods for detecting cancer metastasis | |
| GB201322800D0 (en) | Prostate cancer biomarkers | |
| WO2015095862A3 (en) | Microrna biomarkers for ovarian cancer | |
| ZA201409006B (en) | Diabetes biomarkers | |
| IL242551A (en) | Expectation markers for cancer treatment | |
| EP3030906A4 (en) | Biomarkers for ovarian cancer | |
| GB201104556D0 (en) | Biomarkers | |
| GB201210565D0 (en) | Biomarkers | |
| GB2510539B (en) | Biomarkers of cancer | |
| GB201306339D0 (en) | Biomarkers for prognosis | |
| AP3881A (en) | Combination therapy for ovarian cancer | |
| ZA201504169B (en) | Anti-adam28 antibody for treating cancer | |
| EP3033617A4 (en) | Biomarkers for prostate cancer |